Schuldesz, A.C.; Maganti, R.K.; Tudor, R.; Cornea, A.; Prodan, M.; Toma, A.-O.; Fericean, R.M.; Simu, M.
Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis. Diseases 2024, 12, 127.
https://doi.org/10.3390/diseases12060127
AMA Style
Schuldesz AC, Maganti RK, Tudor R, Cornea A, Prodan M, Toma A-O, Fericean RM, Simu M.
Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis. Diseases. 2024; 12(6):127.
https://doi.org/10.3390/diseases12060127
Chicago/Turabian Style
Schuldesz, Amanda Claudia, Ram Kiram Maganti, Raluca Tudor, Amalia Cornea, Mihaela Prodan, Ana-Olivia Toma, Roxana Manuela Fericean, and Mihaela Simu.
2024. "Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis" Diseases 12, no. 6: 127.
https://doi.org/10.3390/diseases12060127
APA Style
Schuldesz, A. C., Maganti, R. K., Tudor, R., Cornea, A., Prodan, M., Toma, A.-O., Fericean, R. M., & Simu, M.
(2024). Impact of Ocrelizumab on Disease Progression, Memory Improvement, and Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal MRI and Clinical Criteria Analysis. Diseases, 12(6), 127.
https://doi.org/10.3390/diseases12060127